Comparison of Quarterly Earnings Reports
Pharmaceutical Sector Companies
Updated 11/01/04
Current publicly reported financial results (in $millions) for genomics-based companies. Please note that all figures may reflect non-recurring charges, credits, gains or losses. Company fiscal years may not run according to the calendar year. Earnings will be updated as Network Science receives the data.
Comparison of Results for 2000/1999
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $39.9 | $24.3 | $111.0 | $40.2 | $180.7 | $186.3 | $237.1 | $89.4 | $568.7 | $340.2 |
| Wyeth | $337.8 | ($378.5) | $450.6 | $14.0 | $182.3 | $3,636.0 | $38.7 | ($4,415.2) | $1,009.4 | ($1,143.7) |
| AstraZeneca | ($718.0) | ($32.0) | $626.0 | $540.0 | $1,567.0 | ($458.0) | $228.0 | ($31.0) | $1,703.0 | $19.0 |
| Aventis | 1,852.00 | (543.00) | ||||||||
| Bayer | 337.00 | (315.00) | 1,615.00 | (219.00) | 1,623.00 | (31.00) | 3,575.00 | (565.00) | ||
| Bristol-Myers Squibb (BMS) | ($403.0) | $155.0 | ($502.0) | $139.0 | ($477.0) | $139.0 | ($624.0) | $17.0 | ($2,006.0) | $450.0 |
| Eli Lilly (LLY) | $195.5 | $219.8 | $280.0 | $89.8 | $226.8 | $46.2 | $157.5 | ($19.0) | $859.8 | $336.8 |
| Glaxo Wellcome (£) | ||||||||||
| Hoffmann-La Roche (SFr) | 3,372.0 | 4,338.4 | ||||||||
| ICN Pharmaceuticals (ICN) | $16.3 | $4.8 | $14.2 | $5.2 | $25.6 | $4.8 | ($3.3) | ($34.1) | $52.8 | ($19.3) |
| Johnson & Johnson (JNJ) | $580.0 | $176.0 | $699.0 | $199.0 | $689.0 | $224.0 | $231.0 | $137.0 | $2,199.0 | $736.0 |
| Merck (MRK) | $1,314.7 | $200.0 | $1,458.9 | $243.6 | $2,372.3 | $296.4 | $2,503.6 | $190.8 | $7,649.5 | $930.8 |
| Novartis (SFr) | (3,353.00) | (148.00) | ||||||||
| Pfizer | $3,234.7 | ($1,019.0) | $473.0 | ($11.0) | $3,166.0 | $660.0 | $3,599.0 | $466.0 | $10,472.7 | $96.0 |
| Pharmacia Corp | $72.0 | ($495.0) | $828.0 | ($57.0) | $551.0 | $18.0 | ($891.0) | $119.0 | $560.0 | ($415.0) |
| Schering-Plough (SGP) | $203.0 | $89.0 | $191.0 | $87.0 | $161.0 | $73.0 | $127.4 | $65.0 | $682.4 | $314.0 |
| SmithKline Beecham | ($206.0) | $40.0 | ($282.0) | $65.0 | $195.0 | $324.0 | ($293.0) | $429.0 | ||
| Totals | $10,556.9 | $664.4 | $11,247.7 | $2,934.8 | $15,401.7 | $6,227.7 | $9,342.0 | ($1,249.1) | $49,590.2 | $8,431.8 |
Comparison of Results for 2001/2000
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $206.7 | ($916.6) | $728.9 | ($156.2) | $863.3 | ($23.0) | $740.1 | ($139.8) | $2,539.0 | ($1,235.6) |
| American Home (AHP) | $221.4 | $457.2 | ($10.4) | $64.3 | $166.0 | ($510.0) | $177.5 | $4,644.7 | $554.5 | $4,656.2 |
| AstraZeneca | $99.0 | $121.0 | ($1,575.0) | $8.0 | $153.0 | $57.0 | $222.0 | $193.0 | ($1,101.0) | $379.0 |
| Aventis (in Euros) | 589.0 | 59.0 | (35.0) | 39.0 | (73.0) | 265.0 | 155.0 | 994.0 | 636.0 | 1,357.0 |
| Bayer (In Euros) | 570.00 | (114.00) | 164.00 | 87.00 | (749.0) | (717.0) | (681.0) | (104.0) | (696.00) | (848.00) |
| Bristol-Myers Squibb (BMS) | $238.0 | $115.0 | $291.0 | $110.0 | $180.0 | $9.0 | $162.0 | $91.0 | $871.0 | $325.0 |
| Eli Lilly (LLY) | $354.6 | ($38.7) | $411.9 | $161.5 | $62.0 | ($208.7) | ($149.1) | ($191.9) | $679.4 | ($277.8) |
| GlaxoSmithKline | $1,008.0 | ($684.0) | $428.0 | ($120.0) | $629.0 | ($542.0) | $704.0 | ($1,256.0) | $2,769.0 | ($2,602.0) |
| Hoffmann-La Roche (in CHF) | (357.0) | (3,683.0) | (357.0) | (3,683.0) | ||||||
| ICN Pharmaceuticals (ICN) | $6.7 | ($6.4) | $13.0 | ($9.8) | ($24.9) | ($48.3) | $53.1 | $29.2 | $47.9 | ($35.3) |
| Johnson & Johnson (JNJ) | $536.0 | $238.0 | $509.0 | $119.0 | $620.0 | $206.0 | $1,117.0 | $214.0 | $2,782.0 | $777.0 |
| Merck (MRK) | $2,493.7 | $157.7 | $2,416.0 | $93.7 | $1,351.6 | $112.2 | $1,091.0 | $96.9 | $7,352.3 | $460.5 |
| Novartis (in CHF) | 494.00 | (149.00) | 803.00 | 482.00 | 788.00 | 126.00 | 446.00 | 54.00 | 2,531.00 | 513.00 |
| Pfizer (PFE) | $422.3 | $2,134.0 | $633.0 | $679.0 | $666.0 | $711.0 | $75.0 | $536.0 | $1,796.3 | $4,060.0 |
| Pharmacia Corp | ($962.0) | $421.0 | ($1,886.0) | $258.0 | $177.0 | $176.0 | $347.0 | $73.0 | ($2,324.0) | $928.0 |
| Schering-Plough (SGP) | ($83.0) | ($64.0) | ($8.0) | $0.0 | ($6.0) | $10.0 | $53.0 | ($428.0) | ($44.0) | ($482.0) |
| Totals | $4,541.4 | $1,934.2 | $1,951.4 | $1,207.5 | $4,837.0 | ($50.8) | $4,592.5 | $3,862.1 | $15,922.3 | $6,953.0 |
Comparison of Results for 2002/2001
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $629.1 | $1,077.9 | $215.8 | $63.3 | $160.0 | $88.7 | $394.2 | $13.5 | $1,399.1 | $1,243.4 |
| American Home (AHP) | $226.2 | $138.3 | $319.4 | $122.9 | ($45.9) | $1,149.3 | $130.5 | $751.3 | $630.2 | $2,161.9 |
| AstraZeneca | $355.0 | $175.0 | $213.0 | $89.0 | $400.0 | ($36.0) | $535.0 | ($298.0) | $1,619.0 | ($70.0) |
| Aventis (in Euros) | (1,513.0) | 113.0 | (1,333.0) | 94.0 | (1,122.0) | 169.0 | (1,381.0) | 200.0 | (5,350.0) | 576.0 |
| Bayer (In Euros) | (668.0) | 81.0 | (567.0) | (271.0) | 528.0 | 839.0 | 512.0 | (557.0) | (195.0) | 92.0 |
| Bristol-Myers Squibb (BMS) | ($28.0) | ($480.0) | ($582.0) | ($722.0) | ($206.0) | ($906.0) | ($152.0) | ($786.0) | $132.0 | ($2,800.0) |
| Eli Lilly (LLY) | ($244.7) | ($177.6) | ($258.3) | ($169.2) | ($88.4) | $113.8 | $126.7 | $160.9 | ($464.7) | ($72.1) |
| GlaxoSmithKline | $409.0 | $455.0 | $626.0 | $272.0 | $553.0 | $691.0 | $727.0 | $480.0 | $7,044.0 | $630.0 |
| Hoffmann-La Roche (in CHF) | 286.0 | (719.0) | 291.0 | (7,006.0) | 577.00 | (7,725.0) | ||||
| ICN Pharmaceuticals (ICN) | ($14.0) | ($12.6) | ($23.6) | $11.1 | $33.5 | ($63.2) | ($62.7) | ($134.3) | ($111.0) | ($198.9) |
| Johnson & Johnson (JNJ) | $888.0 | $282.0 | $894.0 | $172.0 | $1,021.0 | $288.0 | $1,178.0 | $333.0 | $3,981.0 | $983.0 |
| Merck (MRK) | $824.2 | ($32.3) | $276.2 | ($190.4) | ($6,493.5) | ($64.2) | ($6,500.3) | $28.9 | ($26,270.0) | ($132.3) |
| Novartis (in CHF) | 743.0 | 303.0 | 244.0 | (184.0) | (124.0) | 72.0 | (94.0) | 98.0 | 769.0 | 289.0 |
| Pfizer (PFE) | $163.0 | $33.0 | ($326.0) | $128.0 | $901.0 | $278.0 | $1,153.0 | $900.0 | $3,349.0 | $1,339.0 |
| Pharmacia Corp | ($83.0) | $856.0 | $252.0 | $170.0 | ($887.0) | ($857.0) | $51.0 | $54.0 | $159.0 | $143.0 |
| Schering-Plough (SGP) | $250.0 | $36.0 | $215.0 | ($1.0) | $44.0 | ($172.0) | ($101.0) | $170.0 | $408.0 | $33.0 |
| Totals | $3,374.8 | $2,350.7 | $1,821.5 | ($54.3) | ($5,449.5) | $510.4 | ($2,520.6) | $1,673.4 | ($8,124.3) | $3,259.9 |
Comparison of Results for 2003/2002
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $391.5 | ($53.3) | ($188.6) | ($345.7) | ($93.3) | $41.1 | $691.4 | $317.3 | $800.9 | ($40.6) |
| American Home (AHP) | $45.6 | $406.0 | $243.8 | $264.5 | $457.9 | ($1,827.8) | $519.4 | ($1,238.7) | $1,266.7 | ($2,396.0) |
| AstraZeneca | $389.0 | ($26.0) | $124.0 | ($109.0) | $521.0 | $128.0 | ($26.0) | $207.0 | $1,008.0 | $200.0 |
| Aventis (in Euros) | (98.0) | (229.0) | 33.0 | 105.0 | 25.0 | 80.0 | (167.0) | 132.0 | (207.0) | 88.0 |
| Bayer (In Euros) | 123.0 | 63.0 | (248.0) | 165.0 | (625.0) | (779.0) | (763.0) | (1,540.0) | (1,513.00) | (2,091.00) |
| Bristol-Myers Squibb (BMS) | $67.0 | ($64.0) | $1,002.0 | $423.0 | $835.0 | $567.0 | $777.0 | $55.0 | $2,681.0 | $981.0 |
| Eli Lilly (LLY) | $328.4 | ($222.2) | $313.0 | $33.7 | $353.8 | $30.5 | $509.9 | $10.9 | $1,505.1 | ($147.1) |
| GlaxoSmithKline | $1,048.0 | $460.0 | $752.0 | $421.0 | $1,056.0 | $656.0 | $488.0 | ($478.0) | $3,344.0 | $1,059.0 |
| Hoffmann-La Roche (in CHF) | 451.0 | (512.0) | 908.0 | 7,606.0 | 1,359.00 | 7,094.00 | ||||
| ICN Pharmaceuticals (ICN) | ($26.3) | $5.3 | $2.7 | ($17.5) | ($4.2) | ($7.5) | ($23.4) | $98.9 | ($51.2) | $79.2 |
| Johnson & Johnson (JNJ) | $1,079.0 | $237.0 | $1,259.0 | ($444.0) | $1,376.0 | $255.0 | $1,851.0 | $407.0 | $5,565.0 | $455.0 |
| Merck (MRK) | ($6,597.9) | $85.4 | ($6,643.9) | $242.0 | $335.9 | ($25.7) | ($430.6) | ($494.6) | ($13,336.5) | ($192.9) |
| Novartis | $979.0 | ($1.0) | $1,010.0 | $30.0 | $837.0 | $89.0 | $1,161.0 | $173.0 | $3,987.0 | $291.0 |
| Pfizer (PFE) | $778.0 | $2,702.0 | $2,697.0 | ($5,548.0) | $4,352.0 | ($115.0) | $4,834.0 | ($2,254.0) | $12,661.0 | ($5,215.0) |
| Pharmacia Corp | ||||||||||
| Schering-Plough (SGP) | ($474.0) | ($427.0) | ($525.0) | ($451.0) | ($423.0) | ($694.0) | ($422.0) | ($494.0) | ($1,844.0) | ($2,066.0) |
| Totals | ($2,971.7) | $3,103.2 | ($964.1) | ($5,531.0) | $8,767.1 | ($992.4) | $8,768.7 | ($3,863.2) | $13,600.0 | ($7,283.4) |
Comparison of Results for 2004/2003
| Q1 | Q2 | Q3 | Q4 | YTD | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | Revenue | Income | |
| Abbott (ABT) | $635.5 | $21.9 | $576.8 | $387.6 | $433.8 | $42.9 | $1,646.1 | $452.4 | ||
| AstraZeneca | $339.0 | ($131.0) | $852.0 | $167.0 | $462.0 | $408.0 | $1,653.0 | $444.0 | ||
| Aventis (In Euros) | (229.0) | 355.0 | (172.0) | (2.0) | (401.0) | 353.0 | ||||
| Bayer (in Euros) | 6.0 | (186.0) | 6.0 | (186.0) | ||||||
| Bristol-Myers Squibb (BMS) | $453.0 | $172.0 | $301.0 | ($375.0) | $55.0 | ($148.0) | $809.0 | ($351.0) | ||
| Eli Lilly (LLY) | $487.5 | ($6.6) | $468.1 | ($35.3) | $141.0 | $40.8 | $1,096.6 | ($1.1) | ||
| GlaxoSmithKline | $691.0 | $137.0 | $461.0 | ($59.0) | $334.0 | $56.0 | $1,486.0 | $134.0 | ||
| Hoffmann-La Roche (in CHF) | 225.00 | 1,631.00 | 225.00 | 1,631.00 | ||||||
| Johnson & Johnson (JNJ) | $1,737.0 | $422.0 | $1,152.0 | $1,248.0 | $1,098.0 | $269.0 | $3,987.0 | $1,939.0 | ||
| Merck (MRK) | $59.4 | ($91.8) | $496.3 | ($98.9) | ($223.9) | ($532.7) | $331.8 | ($723.4) | ||
| Novartis | $918.0 | $230.0 | $770.0 | $233.0 | $847.0 | $270.0 | 2,535.0 | 733.0 | ||
| Pfizer (PFE) | $3,962.0 | ($2,334.0) | $2,281.0 | $6,454.0 | $483.0 | $1,106.0 | $6,726.0 | $5,226.0 | ||
| Schering-Plough (SGP) | ($119.0) | ($246.0) | ($161.0) | ($247.0) | ($20.0) | $291.0 | ($300.0) | ($202.0) | ||
| Valeant Pharmaceuticals (VRX) | ($1.0) | ($27.3) | ($13.1) | ($56.2) | ($1.1) | $66.5 | ($15.2) | ($17.0) | ||
| Wyeth (WYE) | $325.7 | ($528.2) | $476.6 | ($37.0) | $390.2 | $1,847.7 | $1,192.5 | $1,282.5 | ||
| Totals for Results in USD | $9,488.1 | ($2,382.0) | $7,660.7 | $7,581.2 | $3,999.0 | $3,717.2 | $21,147.8 | $8,916.5 | ||
